Drug Detection Panel and THC Metabolite, Umbilical Cord Tissue, Qualitative
Also known as: C PAN_THC
Use
The Drug Detection Panel and THC Metabolite test is intended to detect and document fetal drug exposure during approximately the last trimester of a full-term pregnancy. This test is used to reflect maternal drug use and can report the presence of over 60 substances, including opioids, stimulants, sedatives/hypnotics, and metabolites of THC. It serves as a clinical tool to understand potential drug exposure but does not ascertain the frequency or pattern of drug use.
Special Instructions
Not provided.
Limitations
This test cannot distinguish between delta-8 and delta-9 THC forms or their metabolites. A negative result does not exclude the possibility of maternal drug use during pregnancy, as detection is contingent upon multiple factors, including the stability of the drug, maternal usage level, deposition characteristics, and the analytical method's performance.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 62364-5 - Test performance info Spec
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Container
Routine urine collection cup or Security Kit for Meconium/Umbilical Drug Detection (ARUP supply #51548)
Collection Instructions
Drain and discard any blood from the umbilical cord. Rinse exterior with normal saline or water. Pat dry before transport.
Storage Instructions
Transport refrigerated.
Causes for Rejection
Cords soaking in blood or other fluid. Formalin fixed. Tissue that is obviously decomposed.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 3 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant